Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2828919 | 0.98 | KMT2A (0.52) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL8716342 | 0.98 | KMT2A (0.52) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL22127720 | 0.98 | KMT2A (0.52) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL20773076 | 0.98 | KMT2A (0.52) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL5613043 | 0.98 | KMT2A (0.52) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL7292793 | 0.94 | KMT2A (0.48) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL7292797 | 0.94 | KMT2A (0.48) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL7278342 | 0.94 | KMT2A (0.48) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL10942351 | 0.88 | TSHR (0.47) | KMT2AMEN1TSHRPOLBL3MBTL1 | |
| SCHEMBL30471428 | 0.85 | KMT2A (0.41) | KMT2AMEN1TSHRPOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114042429-B | Production device and method of natural delta decalactone spice | 安徽华业香料股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-216630783-U | Production device of natural delta-decalactone spice | 安徽华业香料股份有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-114042429-A | Production device and method of natural delta-decalactone spice | 安徽华业香料股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-110498993-B | Porous PVA/cellulose nanocrystalline hydrogel and preparation method thereof | 芜湖万隆新材料有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-110498993-A | A kind of porous PVA/Cellulose nanocrystal hydrogel and preparation method thereof | CHANGCHUN INST APPLIED CHEMISTRY CAS | 2019-11-26 | — | — | CN | claimed |
| CN-101210017-A | Synthesis of middle position-tetraaryldiphenanthrene dioxyporphyrin derivative and application thereof | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2008-07-02 | — | — | CN | claimed |
| CN-114042429-B | Production device and method of natural delta decalactone spice | 安徽华业香料股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-114042429-B | Production device and method of natural delta decalactone spice | 安徽华业香料股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-216630783-U | Production device of natural delta-decalactone spice | 安徽华业香料股份有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-114042429-A | Production device and method of natural delta-decalactone spice | 安徽华业香料股份有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-114042429-A | Production device and method of natural delta-decalactone spice | 安徽华业香料股份有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-110498993-B | Porous PVA/cellulose nanocrystalline hydrogel and preparation method thereof | 芜湖万隆新材料有限公司 | 2020-05-19 | — | — | CN | disclosed |
| CN-110498993-A | A kind of porous PVA/Cellulose nanocrystal hydrogel and preparation method thereof | CHANGCHUN INST APPLIED CHEMISTRY CAS | 2019-11-26 | — | — | CN | disclosed |
| US-7179937-B2 | Cyclopentenone derivatives for cancer therapy | DABUR RESEARCH FOUNDATION (IN) | 2007-02-20 | — | — | US | disclosed |
| EP-1719746-A1 | OPTICAL RESOLVER, PROCESS FOR PRODUCING OPTICALLY ACTIVE ISOMER, AND 1,5-SUBSTITUTED BICYCLO (3.3.0) -2-OXAOCTANE COMPOUND | ZEON CORPORATION (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1581471-A1 | CYCLOPENTENONE DERIVATIVES FOR CANCER THERAPY | Dabur Research Foundation (IN) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004056738-A1 | CYCLOPENTENONE DERIVATIVES FOR CANCER THERAPY | DABUR RESEARCH FOUNDATION (IN) | 2004-07-08 | — | — | WO | disclosed |
| US-20030229146-A1 | Cyclopentenone derivatives for cancer therapy | DABUR RESEARCH FOUNDATION | 2003-12-11 | — | — | US | disclosed |
| US-4970345-A | REARRANGEMENT, HYDROGENATION, DEHYDRATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-11-13 | — | — | US | disclosed |
| US-4496767-A | REARRANGEMENT, ESTERIFICATION AND REDUCTION OF A FURAN-CARBINOL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229146-A1 | Cyclopentenone derivatives for cancer therapy | MCL1, DLD, PYCR1 | KMT2A 4204/4885MEN1 2456/4885TSHR 4317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.